A significant advancement in hepatitis B vaccination has emerged, especially beneficial for individuals living with HIV. According to research led by a Weill Cornell Medicine investigator, a newer hepatitis B vaccine known as HepB-CpG (trade name Heplisav-B) demonstrates substantially superior
The approval of ticagrelor, an anti-platelet drug marketed as Brilinta in the US and Brilique in Europe, has been mired in controversy since the publication of the PLATO trial. This landmark clinical trial, which led to the drug's worldwide approval, has faced intense scrutiny over the validity and
Hodgkin lymphoma, a rare but treatable blood cancer, primarily impacts younger individuals aged 20-40. Effective treatment is crucial, but so is the consideration of long-term health and quality of life for patients. Recent advancements in chemotherapy regimens have shown promise in reducing
The PROSPECT-Lung trial has officially commenced, heralding a significant advance in the quest to enhance treatment strategies for patients with resectable non-small cell lung cancer (NSCLC). This trial marks the inaugural endeavor of the newly established National Cancer Institute (NCI) Clinical
The findings from the late-breaking research presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition have brought new insights into the treatment of mantle cell lymphoma (MCL). The phase 3 study EA4151, conducted by the ECOG-ACRIN Cancer Research Group, investigated
The relationship between dietary fructose, particularly from high-fructose corn syrup, and cancer growth is a topic of growing concern. Over the past few decades, the consumption of high-fructose corn syrup has skyrocketed. While naturally occurring fructose in fruits, vegetables, and honey is
